Chlorpheniramine
Substituted Alkylamines
Sold as GALPSEUD PLUS LINCTUS
- Drug class
- Substituted Alkylamines
- Availability
- See label
- Routes
- Subcutaneous
- Markets covered
- 2
- Products on record
- 21
Overview
Chlorpheniramine is an active pharmaceutical ingredient in the Substituted Alkylamines group (R06AB). The information below is compiled per regulator from the product labels on record, with direct links to the original documents.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| GB United Kingdom | MHRA | 20 | May 29, 2026 |
| CA Canada | Health Canada | 1 | March 22, 2025 |
GBUnited Kingdom· MHRA
20 products
Uses
For the relief of symptoms caused by allergic conditions such as hayfever, allergic rhinitis, perennial rhinitis, vasomotor rhinitis, urticaria and skin rashes, angioneurotic oedema, drug and serum reactions, food allergy, insect bites etc, which are responsive to antihistamines.
Indicated for the symptomatic relief of itch associated with chickenpox.
How to take
CACanada· Health Canada
1 product
1 product on record with this regulator. Detailed label text (uses, dosage, side effects) is being ingested — the original document is linked under Sources [2].
Drug interactions
Known interactions involving Chlorpheniramine. Select one for details. This list is informational and not a complete interaction checker.
Showing 240 of 325. Type above to find a specific drug.
Interaction data compiled from DDInter (academic, CC-BY). Severity classification only - this is not a complete interaction checker and not medical advice.
Sources & citations
- [1]MHRA (UK) · PL556120067 · revised May 29, 2026
- [2]Health Canada (DPD) · 02240953 · revised March 22, 2025
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.